NORMAL AND ABNORMAL RESTING CORONARY TRANSIT TIME IN PATIENTS UNDERGOING TESTING FOR CORONARY MICROVASCULAR FUNCTION USING BOLUS THERMODILUTION
Thomas M. Das(Cleveland Clinic), Khaled M. Ziada(Cleveland Clinic), Laura Young(Cleveland Clinic), Odette Iskandar(Cleveland Clinic), Stephen G. Ellis(Université de Perpignan), Maryam Muhammad Ali Majeed-Saidan(Cleveland Clinic), Chaitanya Chennareddy(Cleveland Clinic), Kara Denby(Saint Alphonsus Regional Medical Center)
Cited by 0
Related Papers
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction
|Journal of the American College of Cardiology|2015|831